The effect of aprotinin, tranexamic acid, and aminocaproic acid on blood loss and use of blood products in major pediatric surgery: A meta-analysis

Pediatric Critical Care Medicine

Volumn 10, Issue 2, 2009, Pages 182-190

  Schouten, Esther S ^a   Van De Pol, Alma C ^a   Schouten, Anton N J ^a   Turner, Nigel M ^a   Jansen, Nicolaas J G ^a   Bollen, Casper W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Aminocaproic acid, meta analysis; Aprotinin; Cardiac surgery; Pediatric; Tranexamic acid

Indexed keywords

AMINOCAPROIC ACID; APROTININ; PLACEBO; TRANEXAMIC ACID; AMINOCAPROIC ACID DERIVATIVE; HEMOSTATIC AGENT;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HEART ARREST; HEART ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HEART FAILURE; HEART SURGERY; HEMOSTASIS; HUMAN; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCOLIOSIS; SPINE SURGERY; SURGICAL PATIENT; SYSTEMATIC REVIEW; TACHYCARDIA; BLEEDING; BLOOD TRANSFUSION; CHILD; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; THORAX SURGERY; UTILIZATION REVIEW;

AMINOCAPROIC ACIDS; APROTININ; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CHILD; HEMOSTATICS; HUMANS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCOLIOSIS; THORACIC SURGERY; TRANEXAMIC ACID;

EID: 68649128707     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181956d61     Document Type: Review

References (50)

1. Kneyber MC, Hersi MI, Twisk JW, et al: Red blood cell transfusion in critically ill children is independently associated with increased mortality. Intensive Care Med 2007; 33: 1414-1422
2. Guay J, Rivard GE: Mediastinal bleeding after cardiopulmonary bypass in pediatric patients. Ann Thorac Surg 1996; 62:1955-1960
3. Williams GD, Bratton SL, Ramamoorthy C: Factors associated with blood loss and blood product transfusions: A multivariate analysis in children after open-heart surgery. Anesth Analg 1999; 89:57-64
4. Chan AK, Leaker M, Burrows FA, et al: Coagulation and fibrinolytic profile of paediat-ric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997; 77:270-277
5. Mojcik CF, Levy JH: Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. Ann Thorac Surg 2001; 71:745-754
6. Peters DC, Noble S: Aprotinin: An update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 1999; 57:233-260
7. Meert KL, Kannan S, Mooney JF: Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine 2002; 27:2137-2142
8. Slaughter TF, Greenberg CS: Antifibrinolytic drugs and perioperative hemostasis. Am J Hematol 1997; 56:32-36
9. Arnold DM, Fergusson DA, Chan AK, et al: Avoiding transfusions in children undergoing cardiac surgery: A meta-analysis of ran- domized trials of aprotinin. Anesth Analg 2006; 102:731-737
10. Mangano DT, Tudor IC, Dietzel C: The risk associated with aprotinin in cardiac surgery. N Engl J Med 2006; 354:353-365
11. Mangano DT, Miao Y, Vuylsteke A, et al: Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. JAMA 2007; 297:471-479
12. Ferguson TB Jr: Aprotinin-Are there lessons learned? JAMA 2007; 297:527-529
13. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 1996; 17:1-12
14. Current JD: A linear equation for estimating the body surface area in infants and children. The Internet Journal of Anaesthesiology 1998; 2(2)
15. Higgins JP, Thompson SG, Deeks JJ, et al: Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-560
16. Bollen CW, Uiterwaal CS, van Vught AJ: Meta-regression analysis of high-frequency ventilation vs conventional ventilation in infant respiratory distress syndrome. Intensive Care Med 2007; 33:680-688
17. Boldt J, Knothe C, Zickmann B, et al: Apro-tinin in pediatric cardiac operations: Platelet function, blood loss, and use of homologous blood. Ann Thorac Surg 1993; 55:1460-1466
18. Boldt J, Knothe C, Zickmann B, et al: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss. J Thorac Cardiovasc Surg 1993; 105:705-711
19. Boldt J, Zickmann B, Schindler E, et al: In-fluence of aprotinin on the thrombomodulin/ protein C system in pediatric cardiac operations. J Thorac Cardiovasc Surg 1994; 107: 1215-1221
20. Coniff RF: The Bayer 022 compassionate-use pediatric study. Ann Thorac Surg 1998; 65(Suppl 6):S31-S33
21. D'Errico CC, Shayevitz JR, Martindale SJ, et al: The efficacy and cost of aprotinin in children undergoing reoperative open heart surgery. Anesth Analg 1996; 83:1193-1199
22. Davies MJ, Allen A, Kort H, et al: Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations. Ann Thorac Surg 1997; 63:497-503
23. Dietrich W, Mossinger H, Spannagl M, et al: Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations. J Thorac Cardiovasc Surg 1993; 105: 712-720
24. Gomar C, del Pozo D, Fita G, et al: Aprotinin in paediatric surgery: blood loss and use of blood products. Br J Anaesthesia 1995; 74:33
25. Herynkopf F, Lucchese F, Pereira E, et al: Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study. J Thorac Cardiovasc Surg 1994; 108(3):517-521
26. Huang H, Ding W, Su Z, et al: Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106:11-18
27. Miller BE, Tosone SR, Tam VK, et al: Hema-tologic and economic impact of aprotinin in reoperative pediatric cardiac operations. Ann Thorac Surg 1998; 66:535-540
28. Mossinger H, Dietrich W, Braun SL, et al: High-dose aprotinin reduces activation of he-mostasis, allogeneic blood requirement, and duration of postoperative ventilation in pediatric cardiac surgery. Ann Thorac Surg 2003; 75:430-437
29. Seghaye MC, Duchateau J, Grabitz RG, et al: Influence of low-dose aprotinin on the in-flammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996; 61:1205-1211
30. Chauhan S, Bisoi A, Modi R, et al: Tranex-amic acid in paediatric cardiac surgery. Indian J Med Res 2003; 118:86-89
31. Chauhan S, Bisoi A, Kumar N, et al: Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann 2004; 12:121-124
32. Levin E, Wu J, Devine DV, et al: Hemostatic parameters and platelet activation marker expression in cyanotic and acyanotic pediatric patients undergoing cardiac surgery in the presence of tranexamic acid. Thromb Haemost 2000; 83:54-59
33. Reid RW, Zimmerman AA, Laussen PC, et al: The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. Anesth Analg 1997; 84:990-996
34. Zonis Z, Seear M, Reichert C, et al: The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. J Thorac Cardiovasc Surg 1996; 111:982-987
35. Chauhan S, Das SN, Bisoi A, et al: Comparison of epsilon aminocaproic acid and tran-examic acid in pediatric cardiac surgery. J Cardiothorac Vasc Anesth 2004; 18: 141-143
36. McClure PD, Izsak J: The use of epsilon-aminocaproic acid to reduce bleeding during cardiac bypass in children with congenital heart disease. Anesthesiology 1974; 40: 604-608
37. Rao BH, Saxena N, Chauhan S, et al: Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss. Indian J Med Res 2000; 111:57-61
38. Bulutcu FS, Ozbek U, Polat B, et al: Which may be effective to reduce blood loss after cardiac operations in cyanotic children: Tranexamic acid, aprotinin or a combination? Paediatr Anaesth 2005; 15:41-46
39. Chauhan S, Kumar BA, Rao BH, et al: Effi-cacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. Ann Thorac Surg 2000; 70:1308-1312
40. Cole JW, Murray DJ, Snider RJ, et al: Apro-tinin reduces blood loss during spinal surgery in children. Spine 2003; 28:2482-2485
41. Florentino-Pineda I, Thompson GH, Poe-Kochert C, et al: The effect of amicar on perioperative blood loss in idiopathic scolio-sis: The results of a prospective, randomized double-blind study. Spine 2004; 29:233-238
42. Khoshhal K, Mukhtar I, Clark P, et al: Effi-cacy of aprotinin in reducing blood loss in spinal fusion for idiopathic scoliosis. J Pedi-atr Orthop 2003; 23:661-664
43. Neilipovitz DT, Murto K, Hall L, et al: A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg 2001; 93:82-87
44. Sethna NF, Zurakowski D, Brustowicz RM, et al: Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology 2005; 102: 727-732
45. Moher D, Cook DJ, Eastwood S, et al: Improving the quality of reports of meta-analyses of randomised controlled trials: The QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999; 354:1896-1900
46. Mannucci PM: Hemostatic drugs. N Engl J Med 1998; 339:245-253
47. Anderson BJ, Morton G, McKenzie I: The use of antifibrinolytic drugs in paediatric cardiac surgery. Paediatr Perinat Drug Ther 2004; 6:4-13
48. Downard CD, Betit P, Chang RW, et al: Impact of AMICAR on hemorrhagic complications of ECMO: A ten-year review. J Pediatr Surg 2003; 38:1212-1216
49. Horwitz JR, Cofer BR, Warner BW, et al: A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg 1998; 33: 1610-1613
50. Wilson JM, Bower LK, Fackler JC, et al: Ami-nocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 1993; 28:536-540